| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4c8fdc6246830fa7458443c3a86f1e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate |
2022-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41a95736cbc19ec48bb8f89fa73ad183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cec151e89c8fa05e410088515886eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f20373c8c530fe10996c1628e0c77205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a309e67eb42a6f316b7411a2bcca393f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3af57e775feb7557320c4cc86a66e37b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b0cce217df135eccdd46fa4af12746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f81717e1b2a69ffc860c431f86d493 |
| publicationDate |
2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114712351-A |
| titleOfInvention |
Application of urticine in the preparation of medicaments for the treatment of inflammatory bowel disease |
| abstract |
The application of urticine of the present invention in preparing medicine for treating inflammatory bowel disease. The present invention first found that urticine has a repairing effect on the damage caused by inflammatory bowel disease; the study found that urticine can significantly reduce the concentration of inflammatory factors in the colon, protect the colon tissue, repair the permeability of the intestinal barrier, and activate AhR, so that it can Reduce intestinal inflammation and restore intestinal barrier permeability. The present invention proposes the application prospect of urticine in the preparation of medicaments for treating inflammatory bowel disease. |
| priorityDate |
2022-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |